Literature DB >> 8381262

Angiotensin converting enzyme in rheumatoid arthritis.

J T Beranek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381262      PMCID: PMC1004972          DOI: 10.1136/ard.52.1.86-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Endothelial cells and normal circulating haemopoietic cells share a number of surface antigens.

Authors:  E J Favaloro; N Moraitis; J Koutts; T Exner; K F Bradstock
Journal:  Thromb Haemost       Date:  1989-04-25       Impact factor: 5.249

2.  Antibody HAM56 is not macrophage-specific in vein autografts.

Authors:  J T Beranek
Journal:  Am J Cardiol       Date:  1991-09-15       Impact factor: 2.778

3.  The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes.

Authors:  B J Nickoloff; C E Griffiths
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

4.  Neovascularization produced by angiotensin II.

Authors:  L A Fernandez; J Twickler; A Mead
Journal:  J Lab Clin Med       Date:  1985-02

5.  The potential aggressiveness of synovial tissue in rheumatoid arthritis.

Authors:  H G Fassbender; M Simmling-Annefeld
Journal:  J Pathol       Date:  1983-03       Impact factor: 7.996

6.  Histamine-modulated transdifferentiation of dermal microvascular endothelial cells.

Authors:  B H Lipton; K G Bensch; M A Karasek
Journal:  Exp Cell Res       Date:  1992-04       Impact factor: 3.905

7.  Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium.

Authors:  S S McCachren
Journal:  Arthritis Rheum       Date:  1991-09

8.  Production of angiotensin converting enzyme by rheumatoid synovial membrane.

Authors:  D Veale; G Yanni; B Bresnihan; O FitzGerald
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

9.  Constitutive production of angiotensin converting enzyme from rheumatoid nodule cells under serum free conditions.

Authors:  M Goto; M Sasano; M Fuzisawa; T Okabe; K Nishizawa
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

10.  Angiogenesis inhibition suppresses collagen arthritis.

Authors:  D J Peacock; M L Banquerigo; E Brahn
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

  10 in total
  1 in total

1.  How adverse drug reactions can play a role in innovative drug research.

Authors:  F Rikken; R Vos
Journal:  Pharm World Sci       Date:  1995-11-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.